Sporotrichosis, a fungal infection instigated by the pathogen Sporothrix species, is attributed to the dimorphic fungus Sporothrix schenckii. Distinguishing itself in the realm of uncommon diseases like sporotrichosis, our company excels by providing all-encompassing, specialized services designed for researchers and scientists involved in this unique field.
Overview of Sporotrichosis
Sporotrichosis is mainly a type of subcutaneous mycosis, impacting the skin, subcutaneous tissue, and lymphatic system. The usual mode of transmission involves the accidental introduction of the fungus into the skin through trauma, frequently from coming into contact with tainted plant matter or soil. Moreover, acquiring this infection through scratches or bites from infected animals is another common avenue. Sporotrichosis presents in two primary forms: cutaneous sporotrichosis and extracutaneous sporotrichosis.
Fig.1 Phylogenetic analysis of the main members of medical relevance in the genus Sporothrix. (Rodrigues, A. M., et al., 2022)
Pathogenesis of Sporotrichosis
Sporotrichosis, a fungal infection primarily triggered by the dimorphic fungus Sporothrix schenckii and its related species, is prevalent in vegetation worldwide, decaying organic material, Sphagnum moss, and soil. This fungus infiltrates the body through skin breaks, often resulting in a minor, painless bump at the entry point. The infection can progress along the lymphatic vessels, causing a series of nodules or ulcers. In certain instances, particularly in individuals with weakened immune systems, the infection may disseminate to other organs like bones, joints, and lungs.
Fig.2 The main antifungal agents and their cellular targets. (Rodrigues, A. M., et al., 2022)
Vaccine and Therapeutic Development for Sporotrichosis
Types |
Names |
Mechanism of Action |
Targets |
Research Phase |
Vaccine development |
MAb P6E7 |
A monoclonal antibody against cell wall Gp70 glycoprotein |
Gp70 glycoprotein |
Preclinical research |
ZR8 peptide |
Induce the cellular immune response |
GP60-70 protein |
Preclinical research |
PGA+CWP100 |
Increase anti-ssCWP IgG, IgG1, IgG2a, and IgG3 levels |
ssCWP |
Preclinical research |
Therapeutic development |
Potassium iodide |
Inhibit biofilm development in Sporothrix |
/ |
Approved |
Itraconazole |
Inhibit the synthesis of ergosterol |
CYP51A1 |
Approved |
Terbinafine |
Inhibitor of ergosterol synthesis |
SQLE |
Approved |
TCAN26 |
Cell membrane disruption |
/ |
Preclinical research |
Buparvaquone |
Mitochondrial dysfunction |
/ |
Preclinical research |
Miltefosine |
Cell membrane disruption |
CCT |
Approved |
Our Services
Our company has advanced infectious disease models, and vaccine and therapeutic development platforms, and excels in providing a seamless service for professionals seeking to delve into the intricacies of rare diseases. From access to cutting-edge laboratory facilities to expert consultation services, we ensure that researchers have all the necessary tools at their disposal to advance their studies on diseases like sporotrichosis.
Featured Services for Sporotrichosis
- Systemic and peritoneal models of sporotrichosis in mice
- Subcutaneous model of sporotrichosis in mice
- Galleria mellonella model of Sporothrix schenckii infection
- Others
By offering a centralized hub of resources and expertise, we empower researchers and scientists to make significant strides in understanding and combating diseases such as sporotrichosis. If you are interested in availing of our services, please do not hesitate to reach out to us for more details and quotations related to our offerings.
References
- Rodrigues, Anderson Messias et al. "Current Progress on Epidemiology, Diagnosis, and Treatment of Sporotrichosis and Their Future Trends." Journal of fungi (Basel, Switzerland) 8.8 (2022): 776.
- Sharma, Bunty et al. "Sporotrichosis: a Comprehensive Review on Recent Drug-Based Therapeutics and Management." Current dermatology reports 11.2 (2022): 110-119.
All of our services and products are intended for preclinical research use
only and cannot be used to diagnose, treat or manage patients.